Current research on respiratory viral infections: Fourth International Symposium.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

17 citing papers in PubMed.

1. A randomized controlled trial of low-dose recombinant human interferons alpha-2b nasal spray to prevent acute viral respiratory infections in military recruits.Vaccine · 2010
   Trial
2. Presence of specific viruses in the middle ear fluids and respiratory secretions of young children with acute otitis media.Journal of medical virology · 2004
   Trial
3. Polyphosphazene-Mediated Assembly of TLR4 and TLR7/8 Agonists Enables a Potent Nano-Adjuvant Delivery System for Hepatitis C Virus Vaccine Antigens.Vaccines · 2025
   Article
4. Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist-Synthesis, Characterization, and In Vivo Activity.Journal of functional biomaterials · 2025
   Article
5. Fluorine-Functionalized Polyphosphazene Immunoadjuvant: Synthesis, Solution Behavior and In Vivo Potency.Molecules (Basel, Switzerland) · 2023
   Article
6. Skin Vaccination with Ebola Virus Glycoprotein Using a Polyphosphazene-Based Microneedle Patch Protects Mice against Lethal Challenge.Journal of functional biomaterials · 2022
   Article
7. Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine.Nanomedicine : nanotechnology, biology, and medicine · 2021
   Article
8. Molecular pharmaceutics · 2021
   Article
9. Polyphosphazene immunoadjuvants: Historical perspective and recent advances.Journal of controlled release : official journal of the Controlled Release Society · 2021
   Review
10. Disseminated adenovirus infection causing severe ARDS.BMJ case reports · 2017
    Article
11. Polyionic vaccine adjuvants: another look at aluminum salts and polyelectrolytes.Clinical and experimental vaccine research · 2015
    Review
12. Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer.The Pediatric infectious disease journal · 2011
    Article
13. Respiratory syncytial virus vaccine development.Clinics in laboratory medicine · 2009
    Review
14. Vaccine containing natural TLR ligands protects from Salmonella typhimurium infection in mice and acute respiratory infections in children.Advances in experimental medicine and biology · 2007
    Review
15. Viral upper respiratory tract infections in young children with emphasis on acute otitis media.International journal of pediatric otorhinolaryngology · 2006
    Review
16. Treatment of respiratory virus infections.Antiviral research · 2006
    Review
17. Current research on respiratory viral infections: Fifth International Symposium.Antiviral research · 2004
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as